HISTORICAL FACTS: 9 | History Defined

IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year

IO Biotech (NASDAQ:IOBT) on Monday released topline results from the pivotal Phase 3 trial of its investigational, immune-modulatory, off-the-shelf therapeutic cancer vaccine, Cylembio (imsapepimut and etimupepimut, adjuvanted).

Benzinga · Aug 11, 2025

Three new cancer drugs approved for use for NHS Scotland

Three new treatments for cancer have been approved for use by the NHS in Scotland ...

The National (Scotland) · Aug 11, 2025

The new take-at-home drug that ‘could boost effectiveness of chemotherapy’

New medicine will spare some patients from more aggressive treatments

The Independent UK · Aug 10, 2025

New technique hailed as ‘powerful double weapon’ against chemo hair loss

The method combines scalp cooling with a special lotion.

Evening Standard · Jul 9, 2025

Alcohol labels should warn of cancer risk, urge health groups

Doctors and health experts have written a letter to Sir Keir Starmer urging the government to tackle a lack of awareness about the links between alcohol consumption and cancer

The Independent UK · Jun 24, 2025

Alcohol should have labels warning drinkers of cancer risks, charities say

Health organisations have written to Keir Starmer urging him to force drinks producers to include warnings

The Guardian - UK · Jun 21, 2025

Banned in Britain, Still on US Shelves: Jolly Ranchers Pulled Over 'Cancer‑Causing' Ingredients

Jolly Rancher sweets have been pulled from UK shelves over ingredients linked to cancer risk. Here's why the US still allows them and what consumers need to know

International Business Times UK · Jun 18, 2025

EPA will revisit Biden-era ban on the last type of asbestos used in US

The Environmental Protection Agency will reconsider a Biden administration ban on the last type of asbestos used in the United States

The Independent UK · Jun 17, 2025

UK-wide drug trial hailed as a ‘milestone’ in leukaemia treatment

Combination of two targeted drugs found to produce better outcomes and was more tolerable than chemotherapy

The Guardian - UK · Jun 16, 2025

‘Milestone’ treatment could reshape future leukaemia care

The Flair trial found that 94 per cent of patients who received the two targeted drugs were alive with no disease progression after five years

The Independent UK · Jun 15, 2025